Prestige Consumer Healthcare Inc (PBH) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2026, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Prestige Consumer Healthcare Inc   (NYSE: PBH)
 

Prestige Consumer Healthcare Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Prestige Consumer Healthcare Inc 's inventory turnover ratio sequentially decreased to 3.06 in the first quarter 2026, unsurprisingly, as the Prestige Consumer Healthcare Inc markets continue to deteriorate, and PBH's faces growing challenges to bring down its inventories. Prestige Consumer Healthcare Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 119 days, from 117 days, in the Mar 31 2026 quarter.

Within Healthcare sector 124 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1004 in the fourth quarter 2026, to 1184.

PBH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Prestige Consumer Healthcare Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBH Inventory Turnover Ratio (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Inventory Growth 24.22 % 7.73 % 7.97 % 1.77 % 0.71 %
Y / Y Cost of Sales Growth 18.83 % 7.09 % -2.33 % -3.17 % -9.92 %
Inventory Turnover Ratio (TTM) 3.06 3.11 3.11 3.19 3.23
PBH's Total Ranking # 1184 # 1004 # 964 # 689 # 800
Average inventory processing period 119 118 118 115 113
Seq. Inventory Growth 19.53 % -2.73 % 2.89 % 3.83 % 3.67 %
Seq. Cost of Sales Growth -4.76 % 7.94 % 3.28 % 11.93 % -14.17 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 28
Healthcare Sector # 125
Overall Market # 1184

Inventory Turnover Ratio Statistics
High Average Low
5.05 3.66 0.29
(Mar 31 2013)   (Mar 31 2012)



PBH Company Profile >> Back to PBH Efficiency Comparisons >> Compare PBH Inventory Turnover Ratio to its Competitors

Financial Statements
Prestige Consumer Healthcare Inc 's Inventories $ 190 Millions Visit PBH's Balance sheet
Prestige Consumer Healthcare Inc 's Cost of Revenues TTM $ 514 Millions Visit PBH's Income Statement
What are PBH's Sales? Visit PBH's Sales by Segment

Other Inventory Turnover Ratios
Prestige Consumer Healthcare Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PBH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PBH's Competitors
Inventory Turnover Ratio for PBH's Suppliers
Inventory Turnover Ratio for PBH's Customers

You may also want to know
PBH's Sales Growth Rates PBH's Pe Price to earnings ratio PBH's Receivables Turnover Ratio PBH's Stock Quote
PBH's Net Income Growth Rates PBH's Ps Price to Sales ratio PBH's Sales per Employee PBH's Asset Turnover Ratio
PBH's Net Margin PBH's Pb Price to Book ratio PBH's Financial Strength Ratios PBH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Lifemd Inc   7.22 $ 22.284  Millions$ 3  Millions
Phathom Pharmaceuticals Inc   7.01 $ 40.929  Millions$ 6  Millions
Precision Optics Corporation Inc   6.97 $ 26.101  Millions$ 4  Millions
Carlisle Companies Incorporated  6.94 $ 3,299.600  Millions$ 476  Millions
Twist Bioscience Corporation  6.62 $ 207.413  Millions$ 31  Millions
Brightspring Health Services Inc   6.35 $ 4,108.953  Millions$ 647  Millions
Puma Biotechnology Inc   6.29 $ 58.199  Millions$ 9  Millions
Kewaunee Scientific Corporation  6.12 $ 196.836  Millions$ 32  Millions
Edap Tms Sa  6.05 $ 60.703  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Align Technology inc   6.00 $ 1,321.762  Millions$ 220  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Avantor Inc   5.50 $ 4,473.000  Millions$ 813  Millions
Cg Oncology Inc   5.47 $ 7.609  Millions$ 1  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions

Date modified: 2026-10-15T05:23:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.